Neuroinflammation driven by microglial activation represents a pivotal pathological mechanism underlying brain injury in Alzheimer's disease (AD), with NLRP3 inflammasome activation being a hallmark feature of this process. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.